Home › Funds › Redmile Group, LLC › RGNX

Redmile Group, LLC position in RGNX

REGENXBIO INC · Health Care

Redmile Group, LLC reported holding 4,368,804 shares of RGNX (REGENXBIO INC) in its Q2 2026 13F filing — a position valued at US$52.3M, representing 3.51% of its reported portfolio and ranking #8 among its reported holdings. Redmile Group, LLC has disclosed RGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.37M sh
Reported value held$52.34M
Portfolio Weight3.51%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's RGNX position evolved

Redmile Group, LLC first disclosed a stake in RGNX in Q3 2023 at 2,574,042 shares (US$42.4M). The position peaked in Q1 2024 at 4,551,556 shares, worth US$95.9M. Across 12 filings, Redmile Group, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,368,804 shares valued at US$52.3M. Notable position changes include a 46% increase in Q4 2023 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.57M $42.37M New
Q4 2023 3.76M $67.50M Add
Q1 2024 4.55M $95.90M Add
Q2 2024 4.57M $53.47M Hold
Q3 2024 4.89M $51.33M Add
Q4 2024 4.79M $37.06M Reduce
Q1 2025 4.79M $34.28M Hold
Q2 2025 4.78M $39.21M Hold
Q3 2025 4.69M $45.29M Reduce
Q4 2025 4.37M $62.91M Reduce
Q1 2026 4.37M $36.61M Hold
Q2 2026 4.37M $52.34M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGNX and 13F data

RGNX (REGENXBIO INC) is a Health Care company. 33 other funds we track also report a position in RGNX — the largest reported positions include 22NW, LP (US$5.9M), Pale Fire Capital SE (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGNX

All RGNX fund holders →

FAQ

How long has Redmile Group, LLC held RGNX?

Redmile Group, LLC has disclosed RGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Redmile Group, LLC's current position in RGNX?

As of Q2 2026, Redmile Group, LLC holds 4.37M shares of RGNX (REGENXBIO INC), valued at $52.34M, representing 3.51% of its reported portfolio and ranking #8.

Has Redmile Group, LLC been buying or selling RGNX?

In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in RGNX. The position peaked in Q1 2024 at 4.55M shares.

Which other funds hold RGNX?

Other major institutional holders of RGNX include 22NW, LP, Pale Fire Capital SE, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.